RCEL icon

Avita Medical

8.17 USD
+0.03
0.37%
At close Apr 1, 3:59 PM EDT
After hours
8.17
+0.00
0.00%
1 day
0.37%
5 days
-12.06%
1 month
-6.41%
3 months
-36.12%
6 months
-22.56%
Year to date
-36.12%
1 year
-47.46%
5 years
41.59%
10 years
14.75%
0
Funds holding %
of 7,398 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

109% more call options, than puts

Call options by funds: $557K | Put options by funds: $266K

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

100% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 14

25% more capital invested

Capital invested by funds: $65.7M [Q3] → $82.4M (+$16.8M) [Q4]

9% more funds holding

Funds holding: 67 [Q3] → 73 (+6) [Q4]

0.99% more ownership

Funds ownership: 23.58% [Q3] → 24.57% (+0.99%) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$14
71%
upside
Avg. target
$18
120%
upside
High target
$22
169%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
D. Boral Capital
Jason Kolbert
30% 1-year accuracy
98 / 328 met price target
169%upside
$22
Buy
Maintained
18 Mar 2025
Lake Street
Brooks O'Neil
27% 1-year accuracy
4 / 15 met price target
71%upside
$14
Buy
Maintained
8 Jan 2025

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
AVITA Medical announces new manufacturing agreement and amended distribution agreement with Stedical Scientific to further commercialization of PermeaDerm.
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
Neutral
GlobeNewsWire
1 month ago
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
Positive
Zacks Investment Research
1 month ago
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know
The mean of analysts' price targets for Avita Medical (RCEL) points to a 52.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know
Positive
Seeking Alpha
1 month ago
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
Neutral
GlobeNewsWire
1 month ago
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on February 18, 2025 at 2:00PM PT.
AVITA Medical to Host Investor Webinar Briefing
Neutral
Seeking Alpha
1 month ago
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Matthew Park - Cantor Fitzgerald Ryan Zimmerman - BTIG Brooks O'Neil - Lake Street Capital Markets Joshua Jennings - TD Cowen Operator Good day, and thank you for standing by. Welcome to the AVITA Medical Fourth Quarter 2024 Earnings Conference Call.
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the fourth quarter and full year ended December 31, 2024.
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Negative
Seeking Alpha
2 months ago
Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish
AVITA Medical's stock plummeted 36.4% after a significant Q4 sales miss, highlighting a pattern of guidance misses. Management's breakeven target shifted to Q4 2025. It also gave 2025 sales guidance of $100-$106 million. The Company will be forced to repay its $40 million OrbiMed loan if its sales follow my projections and company guidance.
Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish
Positive
Seeking Alpha
2 months ago
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini
Negative
Benzinga
2 months ago
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
On Tuesday, Avita Medical, Inc. RCEL revised its revenue guidance for the fourth quarter and full year of 2024.
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
Charts implemented using Lightweight Charts™